234 related articles for article (PubMed ID: 1704033)
1. Influenza A-specific, HLA-A2.1-restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of the M1 protein.
Engelhard VH; Lacy E; Ridge JP
J Immunol; 1991 Feb; 146(4):1226-32. PubMed ID: 1704033
[TBL] [Abstract][Full Text] [Related]
2. Diversity and dominance among TCR recognizing HLA-A2.1+ influenza matrix peptide in human MHC class I transgenic mice.
Man S; Ridge JP; Engelhard VH
J Immunol; 1994 Nov; 153(10):4458-67. PubMed ID: 7963521
[TBL] [Abstract][Full Text] [Related]
3. Species specificity in the interaction of CD8 with the alpha 3 domain of MHC class I molecules.
Newberg MH; Ridge JP; Vining DR; Salter RD; Engelhard VH
J Immunol; 1992 Jul; 149(1):136-42. PubMed ID: 1607650
[TBL] [Abstract][Full Text] [Related]
4. Highly conserved pattern of recognition of influenza A wild-type and variant CD8+ CTL epitopes in HLA-A2+ humans and transgenic HLA-A2+/H2 class I-deficient mice.
Hu N; D'Souza C; Cheung H; Lang H; Cheuk E; Chamberlain JW
Vaccine; 2005 Nov; 23(45):5231-44. PubMed ID: 16099553
[TBL] [Abstract][Full Text] [Related]
5. A single amino acid substitution in HLA-A2 can alter the selection of the cytotoxic T lymphocyte repertoire that responds to influenza virus matrix peptide 55-73.
Shimojo N; Cowan EP; Engelhard VH; Maloy WL; Coligan JE; Biddison WE
J Immunol; 1989 Jul; 143(2):558-64. PubMed ID: 2472444
[TBL] [Abstract][Full Text] [Related]
6. Specificity of peptide binding by the HLA-A2.1 molecule.
Shimojo N; Maloy WL; Anderson RW; Biddison WE; Coligan JE
J Immunol; 1989 Nov; 143(9):2939-47. PubMed ID: 2553813
[TBL] [Abstract][Full Text] [Related]
7. Importance of MHC class 1 alpha2 and alpha3 domains in the recognition of self and non-self MHC molecules.
Newberg MH; Smith DH; Haertel SB; Vining DR; Lacy E; Engelhard VH
J Immunol; 1996 Apr; 156(7):2473-80. PubMed ID: 8786307
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic T cell responses in HLA-A2.1 transgenic mice. Recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element.
Le AX; Bernhard EJ; Holterman MJ; Strub S; Parham P; Lacy E; Engelhard VH
J Immunol; 1989 Feb; 142(4):1366-71. PubMed ID: 2464645
[TBL] [Abstract][Full Text] [Related]
9. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.
Shirai M; Arichi T; Nishioka M; Nomura T; Ikeda K; Kawanishi K; Engelhard VH; Feinstone SM; Berzofsky JA
J Immunol; 1995 Mar; 154(6):2733-42. PubMed ID: 7533182
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2.
Gotch F; Rothbard J; Howland K; Townsend A; McMichael A
Nature; 1987 Apr 30-May 6; 326(6116):881-2. PubMed ID: 2437457
[TBL] [Abstract][Full Text] [Related]
11. Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes.
Bodmer H; Ogg G; Gotch F; McMichael A
Nature; 1989 Nov; 342(6248):443-6. PubMed ID: 2479838
[TBL] [Abstract][Full Text] [Related]
12. The 45 pocket of HLA-A2.1 plays a role in presentation of influenza virus matrix peptide and alloantigens.
Winter CC; Carreno BM; Turner RV; Koenig S; Biddison WE
J Immunol; 1991 May; 146(10):3508-12. PubMed ID: 2026879
[TBL] [Abstract][Full Text] [Related]
13. Genetic evidence for difference between intracellular and extracellular peptides in influenza A matrix peptide-specific CTL recognition.
Matsui M; Moots RJ; Warburton RJ; Peace-Brewer AL; Tussey LG; Quinn DG; McMichael AJ; Frelinger JA
J Immunol; 1995 Feb; 154(3):1088-96. PubMed ID: 7822785
[TBL] [Abstract][Full Text] [Related]
14. Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2.
Robbins PA; Lettice LA; Rota P; Santos-Aguado J; Rothbard J; McMichael AJ; Strominger JL
J Immunol; 1989 Dec; 143(12):4098-103. PubMed ID: 2480387
[TBL] [Abstract][Full Text] [Related]
15. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
[TBL] [Abstract][Full Text] [Related]
16. Identification of three HLA-A*0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus.
Solache A; Morgan CL; Dodi AI; Morte C; Scott I; Baboonian C; Zal B; Goldman J; Grundy JE; Madrigal JA
J Immunol; 1999 Nov; 163(10):5512-8. PubMed ID: 10553078
[TBL] [Abstract][Full Text] [Related]
17. Identification of Her-2/Neu CTL epitopes using double transgenic mice expressing HLA-A2.1 and human CD.8.
Lustgarten J; Theobald M; Labadie C; LaFace D; Peterson P; Disis ML; Cheever MA; Sherman LA
Hum Immunol; 1997 Feb; 52(2):109-18. PubMed ID: 9077559
[TBL] [Abstract][Full Text] [Related]
18. A study of functionally active amino acids involved in the interaction of HLA-A2 or HLA-A3 molecules with cytolytic T lymphocytes.
Healy F; Sire J; Gomard E; Yssel H; Jordan B; Levy JP
J Immunol; 1988 Oct; 141(7):2487-96. PubMed ID: 2459213
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of amino acid substitutions in the beta-sheet floor and alpha-2 helix of HLA-A2 on recognition by alloreactive viral peptide-specific cytotoxic T lymphocytes.
Mattson DH; Shimojo N; Cowan EP; Baskin JJ; Turner RV; Shvetsky BD; Coligan JE; Maloy WL; Biddison WE
J Immunol; 1989 Aug; 143(4):1101-7. PubMed ID: 2473117
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T lymphocyte recognition of HLA-A2 antigens in normal and HLA-Cw3-transgenic mice.
Hämmerling GJ; Hunt T; Dill O; Moreno J
Eur J Immunol; 1989 Apr; 19(4):599-604. PubMed ID: 2786469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]